Nohla Therapeutics raises $45M, gets new HQ as it moves novel leukemia treatment closer to market Seattle startup Nohla Therapeutics has raised another huge funding round as it moves its novel leukemia treatment closer to being… Read More
Fred Hutch spinout Nohla Therapeutics raises $43.5M to develop therapy for Leukemia Seattle-based Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, just announced a whopping $43.5 million… Read More
Fred Hutch study: Cord blood transplants may be more effective for high-risk Leukemia patients When a patient is diagnosed with Leukemia or another blood cancer, they generally undergo long, painful rounds of chemotherapy to… Read More
